Iris Zhi

Associate Professor

NYU Langone Health

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Iris Zhi is an Associate Professor at NYU Langone Health in the United States. Her research focuses on cancer-related fatigue, health-related quality of life in cancer survivors, and the effects of integrative oncology treatments. Recent publications include studies on chemotherapy-induced peripheral neuropathy and innovative approaches to cancer treatment outcomes. Dr. Zhi's work contributes significantly to understanding patient-reported outcomes and improving clinical practices in oncology.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Dori Beeler

Adjunct Assistant Professor

Wake Forest School of Medicine

UNITED STATES

View details

Jung Julie Kang

Yale University Yale Cancer Center

UNITED STATES

View details

Linda E. Carlson

University of Calgary

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Iris Zhi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations.

Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer center

Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.

Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes.

Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.

Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing.

Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations.

Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations

Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.

Collaborators (3)

Dori Beeler

Jung Julie Kang

Linda E. Carlson

Make your next move.